|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號(hào)：B691160 |
| 產(chǎn)品名稱(chēng)：4-tert-Butyldimethylsilyl-6’-carboxy-5’-chloro-4a’-hydroxy S |
| 產(chǎn)品CAS： |
| 規(guī)格含量：50mg |
| 產(chǎn)品價(jià)格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號(hào): |
B691160 |
| 名稱(chēng): |
4-tert-Butyldimethylsilyl-6’-carboxy-5’-chloro-4a’-hydroxy Simvastatin γ-Lactol |
| 別名: |
[3S-[3α,5β,5aα,6α(2S*,4S*),6α,9aα,10S*]]-2,2-Dimethyl-butanoic Acid 10-Chloro-6-[2-[4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]tetrahydro-6-oxo-2H-pyran-2-yl]ethyl]-3,4,5,5a,6,7-hexahydro-2-hydroxy-7-methyl-2H-3,9a-methano-1-benzoxepin-5-yl Ester |
| 參考CAS: |
123852-12-0 - no stereochemistry |
| 分子式: |
C??H??ClO?Si |
| 外觀(guān): |
Light Brown Foam |
| 分子量: |
599.27 |
| 儲(chǔ)存: |
-20°C Freezer, Under inert atmosphere |
| 溶解度: |
Chloroform, Dichloromethane, Ethyl Acetate |
| 類(lèi)別: |
Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
Intermediate in the preparation of Simvastatin derivatives as HMG-COA reductase inhibitor. |
| 參考文獻(xiàn) |
|
|
|
|
?您的位置：
